The eighth annual BreatheCon, a virtual event hosted by the Cystic Fibrosis Foundation that brings together adults with…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Results of three global clinical trials of a new triple-combination CFTR modulator therapy for cystic fibrosis (CF) —  vanzacaftor,…
Treatment with the inhaled antibiotic aztreonam can stabilize lung function in people with cystic fibrosis (CF) who have…
People with cystic fibrosis (CF) who have chronic inflammation in the nose are less likely to need sinus surgery…
Inflammatory molecules that serve as markers of infection or other problems can be measured in the nasal fluid of babies…
A newborn screening program in New Jersey failed to identify cystic fibrosis (CF) in five children, all of whom…
Researchers hope a new tool that can provide disease-specific education and resources about a lung transplant for people with…
Treatment with the inhaled gene therapy 4D-710 led to clinically meaningful quality of life gains for people with…
The first person with cystic fibrosis (CF) has been dosed with CM001, an experimental inhaled therapy being developed by…
Moligo Technologies is teaming up with Nationwide Children’s Hospital on a new project to develop a non-viral gene therapy…